{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:11:56Z","timestamp":1786990316227,"version":"build-2736575974"},"reference-count":87,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.idc.2021.04.009","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T22:14:30Z","timestamp":1628028870000},"page":"735-754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Occupational Health Update"],"prefix":"10.1016","volume":"35","author":[{"given":"Erica S.","family":"Shenoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7, Suppl. S","key":"10.1016\/j.idc.2021.04.009_bib1","first-page":"1","article-title":"Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Shefer","year":"2011","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.idc.2021.04.009_bib2","series-title":"Red Book: 2018-2021 report of the committee on infectious diseases","author":"Kimberlin","year":"2018"},{"key":"10.1016\/j.idc.2021.04.009_bib3","series-title":"APIC text of infection control and epidemiology. Section V. Occupational health","author":"Sebazco","year":"2005"},{"key":"10.1016\/j.idc.2021.04.009_bib4","unstructured":"American Public Health Association, ed Control of Communicable Diseases Manual. 2020. Heymann D, ed."},{"key":"10.1016\/j.idc.2021.04.009_bib5","unstructured":"Centers for Disease Control and Prevention. (2020b). Interim U.S. Guidance for Risk Assessment and Work Restrictions for Healthcare Personnel with Potential Exposure to COVID-19. Retrieved 1\/16\/2021 from https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/guidance-risk-assesmenthcp.html."},{"issue":"6","key":"10.1016\/j.idc.2021.04.009_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ajic.2004.11.011","article-title":"Infection risks following accidental exposure to blood or body fluids in health care workers: a review of pathogens transmitted in published cases","volume":"34","author":"Tarantola","year":"2006","journal-title":"Am J Infect Control"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2021.04.009_bib8","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.2105\/AJPH.2005.075085","article-title":"Preparedness for infectious threats: public-private partnership to develop an affordable vaccine for an emergent threat: the trivalent Neisseria meningitidis ACW135 polysaccharide vaccine","volume":"97","author":"Nelson","year":"2007","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.idc.2021.04.009_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jcv.2011.05.016","article-title":"Blood-borne viruses in health care workers: prevention and management","volume":"52","author":"Deuffic-Burban","year":"2011","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.idc.2021.04.009_bib10","unstructured":"Centers for Disease Control and Prevention. Hepatitis B Questions and Answers for Health Professionals. Available at: https:\/\/www.cdc.gov\/hepatitis\/hbv\/hbvfaq.htm#overview. Accessed 1\/16\/2021."},{"key":"10.1016\/j.idc.2021.04.009_bib11","unstructured":"Centers for Disease Control and Prevention. Hepatitis C Questions and Answers for Health Professionals. Available at: https:\/\/www.cdc.gov\/hepatitis\/hcv\/hcvfaq.htm#section1. Accessed 1\/16\/2021."},{"key":"10.1016\/j.idc.2021.04.009_bib12","unstructured":"Centers for Disease Control and Prevention. HIV\/AIDS. Basic statistics. Retrieved 1\/21\/2021 from http:\/\/www.cdc.gov\/hiv\/basics\/statistics.html."},{"issue":"RR-6","key":"10.1016\/j.idc.2021.04.009_bib13","first-page":"1","volume":"57","author":"Chapman","year":"2008","journal-title":"MMWR Recomm Rep"},{"issue":"8219","key":"10.1016\/j.idc.2021.04.009_bib14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(81)92877-4","article-title":"Survival of hepatitis-B virus after drying and storage for one week","volume":"1","author":"Bond","year":"1981","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.idc.2021.04.009_bib15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1086\/513727","article-title":"Infectivity of hepatitis C virus in plasma after drying and storing at room temperature","volume":"28","author":"Kamili","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12","key":"10.1016\/j.idc.2021.04.009_bib16","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/infdis\/jir535","article-title":"Inactivation and survival of hepatitis C virus on inanimate surfaces","volume":"204","author":"Doerrbecker","year":"2011","journal-title":"J\u00a0Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2021.04.009_bib17","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/infdis\/jit648","article-title":"Hepatitis C virus maintains infectivity for weeks after drying on inanimate surfaces at room temperature: implications for risks of transmission","volume":"209","author":"Paintsil","year":"2014","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2021.04.009_bib18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jmv.1890350402","article-title":"Survival of Hiv-1 activity after disinfection, temperature and Ph changes, or drying","volume":"35","author":"Tjotta","year":"1991","journal-title":"J\u00a0Med Virol"},{"issue":"2","key":"10.1016\/j.idc.2021.04.009_bib19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/jcm.32.2.571-574.1994","article-title":"Survival of human-immunodeficiency-virus in suspension and dried onto surfaces","volume":"32","author":"Vanbueren","year":"1994","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.idc.2021.04.009_bib20","unstructured":"Schillie SF, Murphy TV, Sawyer M, et\u00a0al. CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recomm Rep 2013;62(10):1-19."},{"issue":"3","key":"10.1016\/j.idc.2021.04.009_bib21","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/CMR.16.3.546-568.2003","article-title":"Managing occupational risks for hepatitis C transmission in the health care setting","volume":"16","author":"Henderson","year":"2003","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"10.1016\/j.idc.2021.04.009_bib22","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.ajic.2017.03.011","article-title":"Seroconversion rates among health care workers exposed to hepatitis C virus-contaminated body fluids: The University of Pittsburgh 13-year experience","volume":"45","author":"Egro","year":"2017","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.idc.2021.04.009_bib23","unstructured":"Centers for Disease Control and Prevention. Pertussis: surveillance and reporting. Retrieved 1\/15\/2021 from http:\/\/www.cdc.gov\/pertussis\/surv-reporting.html."},{"issue":"6","key":"10.1016\/j.idc.2021.04.009_bib24","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/01.aids.0000218543.46963.6d","article-title":"Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis","volume":"20","author":"Baggaley","year":"2006","journal-title":"AIDS"},{"issue":"1269","key":"10.1016\/j.idc.2021.04.009_bib25","first-page":"87","article-title":"Transmission of HBV from patient to healthcare worker","volume":"121","author":"Gane","year":"2008","journal-title":"N\u00a0Z Med J"},{"issue":"4","key":"10.1016\/j.idc.2021.04.009_bib26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2893.2002.00350.x","article-title":"Prevalence and risk factors for intrafamilial transmission of hepatitis C virus in Karachi, Pakistan","volume":"9","author":"Akhtar","year":"2002","journal-title":"J\u00a0Viral Hepat"},{"issue":"4","key":"10.1016\/j.idc.2021.04.009_bib27","first-page":"402","article-title":"The Potential for Transmission of Human-Immunodeficiency-Virus through Human Bites","volume":"6","author":"Richman","year":"1993","journal-title":"J\u00a0Acquir Immune Defic Syndr (1988)"},{"issue":"1","key":"10.1016\/j.idc.2021.04.009_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cld.2009.11.005","article-title":"Infection control guidelines for prevention of health care-associated transmission of hepatitis B and C viruses","volume":"14","author":"Michelin","year":"2010","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.idc.2021.04.009_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jama.2011.1828","article-title":"Management of needlestick injuries a house officer who has a needlestick","volume":"307","author":"Henderson","year":"2012","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.idc.2021.04.009_bib30","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1086\/672271","article-title":"Updated US Public Health Service Guidelines for the Management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis","volume":"34","author":"Kuhar","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"10.1016\/j.idc.2021.04.009_bib31","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.idc.2014.08.005","article-title":"Prevention of Human Immunodeficiency Virus and AIDS: postexposure prophylaxis (including health care workers)","volume":"28","author":"Beekmann","year":"2014","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.idc.2021.04.009_bib32","doi-asserted-by":"crossref","first-page":"h3733","DOI":"10.1136\/bmj.h3733","article-title":"Management of sharps injuries in the healthcare setting","volume":"351","author":"Riddell","year":"2015","journal-title":"BMJ"},{"issue":"15","key":"10.1016\/j.idc.2021.04.009_bib33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.15585\/mmwr.mm6715a5","article-title":"Recommendations of the Advisory Committee on Immunization Practices for use of a hepatitis B vaccine with a novel adjuvant","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.idc.2021.04.009_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6906a1","article-title":"Testing and clinical management of health care personnel potentially exposed to hepatitis C virus\u2014CDC guidance, United States, 2020","volume":"69","author":"Moorman","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.idc.2021.04.009_bib35","volume":"vol. 31","year":"2018"},{"issue":"53","key":"10.1016\/j.idc.2021.04.009_bib36","first-page":"1245","article-title":"Occupationally acquired HIV infection among health care workers - United States, 1985-2013","volume":"63","author":"Joyce","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.idc.2021.04.009_bib37","doi-asserted-by":"crossref","first-page":"ofv126","DOI":"10.1093\/ofid\/ofv126","article-title":"Integrating antiretroviral strategies for human immunodeficiency virus prevention: post- and pre-exposure prophylaxis and early treatment","volume":"2","author":"Grant","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.idc.2021.04.009_bib38","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1093\/cid\/civ092","article-title":"Choice of antiretroviral drugs for postexposure prophylaxis for adults and adolescents: a systematic review","volume":"60","author":"Ford","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2021.04.009_bib39","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1086\/501856","article-title":"Pertussis: a continuing hazard for healthcare facilities","volume":"22","author":"Weber","year":"2001","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2021.04.009_bib40","unstructured":"Centers for Disease Control and Prevention. (2018). Interim Statement Regarding Potential Fetal Harm from Exposure to Dolutegravir- Implications for HIV Post-exposure Prophylaxis (PEP). Retrieved 1\/16\/2021 from https:\/\/stacks.cdc.gov\/view\/cdc\/20711."},{"key":"10.1016\/j.idc.2021.04.009_bib43","doi-asserted-by":"crossref","first-page":"B26","DOI":"10.1016\/j.vaccine.2011.12.032","article-title":"The changing and dynamic epidemiology of meningococcal disease","volume":"30","author":"Halperin","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.idc.2021.04.009_bib44","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-015-0524-6","article-title":"Invasive meningococcal disease in the 21st century-An update for the clinician","volume":"15","author":"Dwilow","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.idc.2021.04.009_bib45","unstructured":"National Center for Immunization and Respiratory Diseases. Enhanced Meningococcal Disease Surveillance Report, 2018. Available at: https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRDEMS-Report-2018.pdf. Accessed 1\/16\/2021."},{"issue":"7","key":"10.1016\/j.idc.2021.04.009_bib46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1179\/2047773213Y.0000000119","article-title":"An epidemiological review of changes in meningococcal biology during the last 100 years","volume":"107","author":"Abio","year":"2013","journal-title":"Pathog Glob Health"},{"key":"10.1016\/j.idc.2021.04.009_bib48","unstructured":"Centers for Disease Control and Prevention. (2015). Tetanus: epidemiology and prevention of vaccinepreventable disease. The pink book. Centers for Disease Control and Prevention. Retrieved 1\/21\/2021 from http:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/tetanus.html."},{"issue":"9","key":"10.1016\/j.idc.2021.04.009_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6909a1","article-title":"Meningococcal vaccination: recommendations of the advisory committee on immunization practices, United States, 2020","volume":"69","author":"Mbaeyi","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.idc.2021.04.009_bib50","unstructured":"World Health Organization. Diphtheria reported cases. Available at: https:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/timeseries\/tsincidencediphtheria.html. Accessed 1\/15\/2021."},{"key":"10.1016\/j.idc.2021.04.009_bib51","doi-asserted-by":"crossref","first-page":"569235","DOI":"10.1155\/2015\/569235","article-title":"Strong public health recommendations from weak evidence? Lessons learned in developing guidance on the public health management of meningococcal disease","volume":"2015","author":"Hanquet","year":"2015","journal-title":"Biomed Res Int"},{"issue":"10","key":"10.1016\/j.idc.2021.04.009_bib52","article-title":"Antibiotics for preventing meningococcal infections","author":"Trestioreanu","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"RR-2","key":"10.1016\/j.idc.2021.04.009_bib53","first-page":"1","article-title":"Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"Cohn","year":"2013","journal-title":"MMWR Recomm Rep"},{"issue":"27","key":"10.1016\/j.idc.2021.04.009_bib54","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1016\/j.vaccine.2012.04.023","article-title":"Nosocomial transmission of measles: an updated review","volume":"30","author":"Botelho-Nevers","year":"2012","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.idc.2021.04.009_bib55","doi-asserted-by":"crossref","first-page":"735","DOI":"10.15585\/mmwr.mm6924a2","article-title":"Detection of ciprofloxacin-resistant, \u03b2-lactamase-producing Neisseria meningitidis Serogroup Y Isolates - United States, 2019-2020","volume":"69","author":"McNamara","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.idc.2021.04.009_bib57","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/infdis\/158.1.238","article-title":"Airborne transmission of nosocomial varicella from localized zoster","volume":"158","author":"Josephson","year":"1988","journal-title":"J\u00a0Infect Dis"},{"issue":"28","key":"10.1016\/j.idc.2021.04.009_bib58","first-page":"574","article-title":"Updated recommendations for use of VariZIG - United States, 2013","volume":"62","author":"Marin","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"10.1016\/j.idc.2021.04.009_bib59","doi-asserted-by":"crossref","first-page":"e1003418","DOI":"10.1371\/journal.ppat.1003418","article-title":"Pertussis: challenges today and for the future","volume":"9","author":"Cherry","year":"2013","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.idc.2021.04.009_bib60","first-page":"67","article-title":"Outbreaks of pertussis associated with hospitals--Kentucky, Pennsylvania, and Oregon, 2003","volume":"54","author":"Centers for Disease Control and Prevention (CDC)","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.idc.2021.04.009_bib61","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1086\/513497","article-title":"Two nosocomial pertussis outbreaks and their associated costs - King County, Washington, 2004","volume":"28","author":"Baggett","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"38","key":"10.1016\/j.idc.2021.04.009_bib62","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1016\/j.vaccine.2014.03.097","article-title":"Healthcare providers as sources of vaccine-preventable diseases","volume":"32","author":"Sydnor","year":"2014","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.idc.2021.04.009_bib63","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1086\/647739","article-title":"Pertussis: an underappreciated risk for nosocomial outbreaks","volume":"19","author":"Weber","year":"1998","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"10.1016\/j.idc.2021.04.009_bib64","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jhin.2015.02.016","article-title":"Bordetella pertussis infection in paediatric healthcare workers","volume":"90","author":"Cunegundes","year":"2015","journal-title":"J\u00a0Hosp Infect"},{"issue":"1","key":"10.1016\/j.idc.2021.04.009_bib65","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4161\/hv.36167","article-title":"Seroprevalence study of B. pertussis infection in health care workers in Catalonia, Spain","volume":"11","author":"Urbiztondo","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"10.1016\/j.idc.2021.04.009_bib66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15585\/mmwr.mm6903a5","article-title":"Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the advisory committee on immunization practices - United States, 2019","volume":"69","author":"Havers","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"10.1016\/j.idc.2021.04.009_bib67","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/cid\/cir973","article-title":"A\u00a0comparison of 2 strategies to prevent infection following pertussis exposure in vaccinated healthcare personnel","volume":"54","author":"Goins","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2021.04.009_bib68","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jac\/11.5.407","article-title":"Invitro sensitivity of Bordetella-Pertussis","volume":"11","author":"Zackrisson","year":"1983","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.idc.2021.04.009_bib69","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1128\/AAC.32.1.137","article-title":"Antimicrobial susceptibilities of Bordetella species isolated in a multicenter pertussis surveillance project","volume":"32","author":"Kurzynski","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.idc.2021.04.009_bib70","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/BF01968151","article-title":"Activity of new macrolides against Bordetella-pertussis and Bordetella-parapertussis","volume":"8","author":"Hoppe","year":"1989","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.04.009_bib71","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/infdis\/155.6.1210","article-title":"Use of erythromycin to prevent pertussis in newborns of mothers with pertussis","volume":"155","author":"Granstrom","year":"1987","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.04.009_bib72","first-page":"177","article-title":"Prevention of secondary transmission of pertussis in households with early use of erythromycin","volume":"146","author":"Sprauer","year":"1992","journal-title":"Am J Dis Child"},{"issue":"11","key":"10.1016\/j.idc.2021.04.009_bib73","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/00006454-199511000-00009","article-title":"Field effectiveness of erythromycin prophylaxis to prevent pertussis within families","volume":"14","author":"Deserres","year":"1995","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.idc.2021.04.009_bib74","article-title":"Antibiotics for whooping cough (pertussis) (withdrawn paper. 2007, atr. no. CD004404)","author":"Altunaiji","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.idc.2021.04.009_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6702a1","article-title":"Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"67","author":"Liang","year":"2018","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.idc.2021.04.009_bib76","unstructured":"Centers for Disease Control and Prevention. (2020c). Measles Cases and Outbreaks. Retrieved 1\/21\/2021 from https:\/\/www.cdc.gov\/measles\/cases-outbreaks.html."},{"issue":"9","key":"10.1016\/j.idc.2021.04.009_bib77","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s10096-014-2119-6","article-title":"Healthcare workers as vectors of infectious diseases","volume":"33","author":"Huttunen","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2021.04.009_bib78","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ajic.2012.09.017","article-title":"Measles in health-care settings","volume":"41","author":"Maltezou","year":"2013","journal-title":"Am J Infect Control"},{"issue":"10","key":"10.1016\/j.idc.2021.04.009_bib79","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1086\/647512","article-title":"Selection and use of vaccines for healthcare workers","volume":"18","author":"Weber","year":"1997","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"43","key":"10.1016\/j.idc.2021.04.009_bib80","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.15585\/mmwr.mm6743a5","article-title":"Update: recommendations of the Advisory Committee on Immunization Practices for use of hepatitis A vaccine for postexposure prophylaxis and for preexposure prophylaxis for international travel","volume":"67","author":"Nelson","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.idc.2021.04.009_bib81","series-title":"Prevention of hepatitis A virus infection in the United States: recommendations of the advisory committee on immunization practices, 2020","author":"Nelson","year":"2020"},{"issue":"3","key":"10.1016\/j.idc.2021.04.009_bib82","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0891-5520(20)30413-X","article-title":"Infections resulting from animal bites","volume":"5","author":"Weber","year":"1991","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.idc.2021.04.009_bib83","series-title":"UpToDate","article-title":"Initial management of animal and human bites","author":"Endom","year":"2016"},{"issue":"3","key":"10.1016\/j.idc.2021.04.009_bib84","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1086\/318509","article-title":"Risks and prevention of nosocomial transmission of rare zoonotic diseases","volume":"32","author":"Weber","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2021.04.009_bib85","unstructured":"Centers for Disease Control and Prevention. Rabies: human rabies. Retrieved 1\/15\/2021 from http:\/\/www.cdc.gov\/rabies\/location\/usa\/surveillance\/human_rabies.html."},{"issue":"3","key":"10.1016\/j.idc.2021.04.009_bib86","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/clinids\/9.3.511","article-title":"Is there a risk to contacts of patients with rabies","volume":"9","author":"Helmick","year":"1987","journal-title":"Rev Infect Dis"},{"issue":"10 Suppl 2","key":"10.1016\/j.idc.2021.04.009_bib87","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.ajic.2007.10.007","article-title":"2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings","volume":"35","author":"Siegel","year":"2007","journal-title":"Am J Infect Control"},{"issue":"RR2","key":"10.1016\/j.idc.2021.04.009_bib88","first-page":"1","article-title":"Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies recommendations of the advisory committee on immunization practices","volume":"59","author":"Rupprecht","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.idc.2021.04.009_bib89","unstructured":"Centers for Disease Control and Prevention. (2010). Scabies: Resources for Health Professionals. Retrieved 1\/17\/2021 from https:\/\/www.cdc.gov\/parasites\/scabies\/health_professionals\/control.html."},{"issue":"2","key":"10.1016\/j.idc.2021.04.009_bib90","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1071\/SH14174","article-title":"Syphilis transmission: a review of the current evidence","volume":"12","author":"Stoltey","year":"2015","journal-title":"Sex Health"},{"issue":"Rr-03","key":"10.1016\/j.idc.2021.04.009_bib91","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"issue":"RR1","key":"10.1016\/j.idc.2021.04.009_bib93","first-page":"1","article-title":"Antiviral agents for the treatment and chemoprophylaxis of influenza recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Fiore","year":"2011","journal-title":"MMWR Recomm Rep"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089155202100043X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089155202100043X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:28:37Z","timestamp":1760196517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089155202100043X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S089155202100043X"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2021.04.009","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Occupational Health Update","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2021.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}